TFPI is a colonic crypt receptor for TcdB from hypervirulent clade 2 C. difficile

Jianhua Luo,Qi Yang,Xiaofeng Zhang,Yuanyuan Zhang,Li Wan,Xiechao Zhan,Yao Zhou,Liuqing He,Danyang Li,Dazhi Jin,Ying Zhen,Jing Huang,Yanyan Li,Liang Tao
DOI: https://doi.org/10.1016/j.cell.2022.02.010
IF: 64.5
2022-03-01
Cell
Abstract:The emergence of hypervirulent clade 2 Clostridioides difficile is associated with severe symptoms and accounts for >20% of global infections. TcdB is a dominant virulence factor of C. difficile, and clade 2 strains exclusively express two TcdB variants (TcdB2 and TcdB4) that use unknown receptors distinct from the classic TcdB. Here, we performed CRISPR/Cas9 screens for TcdB4 and identified tissue factor pathway inhibitor (TFPI) as its receptor. Using cryo-EM, we determined a complex structure of the full-length TcdB4 with TFPI, defining a common receptor-binding region for TcdB. Residue variations within this region divide major TcdB variants into 2 classes: one recognizes Frizzled (FZD), and the other recognizes TFPI. TFPI is highly expressed in the intestinal glands, and recombinant TFPI protects the colonic epithelium from TcdB2/4. These findings establish TFPI as a colonic crypt receptor for TcdB from clade 2 C. difficile and reveal new mechanisms for CDI pathogenesis.
cell biology,biochemistry & molecular biology
What problem does this paper attempt to address?